PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 10, 2025Journal of Clinical Medicine4 citationsOpen Access

Benign and Malignant Parotid Gland Tumors: Insights from a Five-Year Northeast Romanian Population

View Full Paper
LULoredana Beatrice UngureanuGrigore T. Popa University of Medicine and PharmacyCGCristina Mihaela GhiciucGrigore T. Popa University of Medicine and PharmacyVCVictor Vlad CostanGrigore T. Popa University of Medicine and Pharmacy

Key Points

  • Benign parotid gland tumors represented 67.3% of cases, indicating a predominance over malignant tumors.
  • Partial parotidectomy was more common for benign tumors, while total parotidectomy was often required for malignant cases, impacting surgical strategies.
  • Malignant tumors were typically diagnosed at a more advanced stage, with 36.4% presenting at stage III.
  • Clinical diagnosis exhibited a high specificity of 96.9%, but low sensitivity of 56%, suggesting room for improvement in detecting malignancies.

Abstract

Background: The majority of parotid gland tumors are benign, while malignant forms are uncommon, affecting fewer than 1 in 100,000 individuals. The main challenge resides in the histopathological complexity and the clinical overlap between benign and malignant parotid tumors, which frequently results in misdiagnosis. Aim: The objective of this research was to evaluate the clinical and histopathological characteristics of parotid gland tumors at a Romanian healthcare center. Materials and methods: A five-year retrospective study was conducted, with the inclusion criterion being the presence of complete clinical, pathological, and surgical records. Results: Of 156 patients included in the study, 67.3% were found to have benign lesions (male/female ratio 1.14:1), and there was a slight male predominance (53.3%). Partial parotidectomy was the most common surgical intervention for benign parotid tumors (59.6%), whereas total parotidectomy was predominantly indicated for malignant tumors, with facial nerve sacrifice occurring in 20% of cases to ensure complete tumor excision. Patients with benign tumors were found to be younger. Malignant tumors were commonly diagnosed at stage III (36.4%), indicative of more advanced disease at the time of diagnosis. Clinical diagnosis showed a high specificity of 96.9%, indicating high accuracy in malignancy suspicion, yet the sensitivity of 56% indicates that a significant number of malignancies were not detected during the initial evaluation. Tumor size was found to be influenced by gender and correlated with surgical methods, suggesting that patient characteristics and tumor biology may impact surgical strategy. Conclusions: This retrospective study highlights differences in gender, tumor size, and surgical approach between benign and malignant parotid gland tumors, offering valuable contributions in terms of diagnostic accuracy and treatment patterns despite a limited number of malignant cases.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ungureanu et al. (2025) studied this question.

synapsesocial.com/papers/68e861857ef2f04ca37e3b4ahttps://doi.org/10.3390/jcm14197087
Ask AI
Helpful
Bookmark
Share
View Full Paper